TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Kontafarma China Holdings Ltd ( (HK:1312) ) has provided an announcement.
Kontafarma China Holdings Ltd held its Annual General Meeting on June 24, 2025, where all proposed resolutions were passed unanimously by shareholders. These resolutions included the adoption of financial statements, re-election of directors, authorization of directors’ fees, re-appointment of auditors, and granting of mandates for securities issuance and share buybacks. The successful passing of these resolutions reflects strong shareholder support and positions the company for continued operational stability and strategic growth.
More about Kontafarma China Holdings Ltd
Kontafarma China Holdings Ltd is a company incorporated in the Cayman Islands, focusing on various business sectors in China. The company is involved in the production and distribution of health and wellness products, pharmaceuticals, and other related services, catering to the growing demand in the Chinese market.
Average Trading Volume: 1,005,957
Technical Sentiment Signal: Sell
Current Market Cap: HK$156.2M
For detailed information about 1312 stock, go to TipRanks’ Stock Analysis page.